Skip to main content
Top
Published in: Inflammation 6/2014

01-12-2014

Lack of Association Between TESPA1 Gene Polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and Ankylosing Spondylitis in a Chinese Population

Authors: Si Liu, Li Liu, Shanshan Wu, Ting Yang, Faming Pan, Laura Laslett, Guo Xia, Yanting Hu, Dazhi Fan, Ning Ding, Shengqian Xu, Guoqi Cai, Li Wang, Lihong Xin

Published in: Inflammation | Issue 6/2014

Login to get access

Abstract

We investigated whether TESPA1 gene polymorphisms were associated with increased risk of developing ankylosing spondylitis (AS). We also studied whether TESPA1 gene interacts with environmental factors. A total of 494 patients with AS and 478 matched healthy controls were genotyped for four SNPs (rs1801876, rs2171497, rs4758994, and rs997173) in the TESPA1 gene. We found no evidence of association between these SNPs and AS susceptibility, and between their haplotypes and the disease. But, patients with rs1801876 GA, GG, and AA genotypes had significantly different Bath Ankylosing Spondylitis Functional Index (BASFI) scores (p = 0.023). There were significantly different visual analogue scale (VAS) night pain assessment scores (p = 0.040) and BASFI scores (p = 0.023) among different genotypes at rs2171497 locus. There were also significantly different chest expansion scores (p = 0.042) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores (p = 0.014) among different genotypes at rs997173 locus. For multiple testing, Bonferroni correction was performed. After Bonferroni correction, clinical characteristics of these three loci showed association between different genotype groups. These findings indicated that the TESPA1 gene is not involved in AS genetic predisposition in the Han Chinese population; however, it may play an important role in the clinical characteristics of AS.
Literature
1.
go back to reference Ge, R., F. Pan, F. Liao, G. Xia, Y. Mei, B. Shen, et al. 2011. Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only study. Molecular Biology Reports 38: 2281–2284.PubMedCrossRef Ge, R., F. Pan, F. Liao, G. Xia, Y. Mei, B. Shen, et al. 2011. Analysis on the interaction between IL-1F7 gene and environmental factors on patients with ankylosing spondylitis: a case-only study. Molecular Biology Reports 38: 2281–2284.PubMedCrossRef
2.
go back to reference Végvári, A., Z. Szabó, S. Szántó, T.T. Glant, K. Mikecz, and Z. Szekanecz. 2009. The genetic background of ankylosing spondylitis. Joint, Bone, Spine 76: 623–628.PubMedCrossRef Végvári, A., Z. Szabó, S. Szántó, T.T. Glant, K. Mikecz, and Z. Szekanecz. 2009. The genetic background of ankylosing spondylitis. Joint, Bone, Spine 76: 623–628.PubMedCrossRef
3.
go back to reference Adrian Cortes, Johanna Hadler, Jenny P Pointon, Philip C Robinson, Tugce Karaderi, and Paul Leo. 2013. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics. Adrian Cortes, Johanna Hadler, Jenny P Pointon, Philip C Robinson, Tugce Karaderi, and Paul Leo. 2013. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics.
4.
go back to reference O’Gala, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control [J]. Nature Medicine 10: 801–805.CrossRef O’Gala, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control [J]. Nature Medicine 10: 801–805.CrossRef
5.
go back to reference Curotto de Lafaille, M.A., and J.J. Lafaille. 2002. CD4 (+) regulatory T cells in autoimmunity and allergy [J]. Current Opinion in Immunology 14: 771–778.PubMedCrossRef Curotto de Lafaille, M.A., and J.J. Lafaille. 2002. CD4 (+) regulatory T cells in autoimmunity and allergy [J]. Current Opinion in Immunology 14: 771–778.PubMedCrossRef
6.
go back to reference Bacchetta, R., S. Gregori, and M.G. Roncarolo. 2005. CD4+ regulatory T cells: Mechanisms of induction and effector function [J]. Autoimmunity Reviews 4(8): 491–496.PubMedCrossRef Bacchetta, R., S. Gregori, and M.G. Roncarolo. 2005. CD4+ regulatory T cells: Mechanisms of induction and effector function [J]. Autoimmunity Reviews 4(8): 491–496.PubMedCrossRef
7.
go back to reference Morris, G.P., and Y.C. Kong. 2006. Interference with CD4+ CD25+ T-cel1-mediated tolerance to experimental autoimmune thyroiditis by glucocorti-coid-induced tumor necrosis factor receptor monoclonal antibody [J]. Journal of Autoimmunity 26(1): 24–31.PubMedCrossRef Morris, G.P., and Y.C. Kong. 2006. Interference with CD4+ CD25+ T-cel1-mediated tolerance to experimental autoimmune thyroiditis by glucocorti-coid-induced tumor necrosis factor receptor monoclonal antibody [J]. Journal of Autoimmunity 26(1): 24–31.PubMedCrossRef
8.
go back to reference Alvarado—Sanchez, B., B. Hernandez—Castro, D. Portales—Perez, et al. 2006. Regulatory T cells in patients with systemic lupus erythematosus [J]. Journal of Autoimmunity 27: 110–118.PubMedCrossRef Alvarado—Sanchez, B., B. Hernandez—Castro, D. Portales—Perez, et al. 2006. Regulatory T cells in patients with systemic lupus erythematosus [J]. Journal of Autoimmunity 27: 110–118.PubMedCrossRef
9.
go back to reference Zhang, L., L.B. Jarvis, H.J. Baek, et al. 2009. Regulatory IL4 CD8 T cells in patients with ankylosing spondylitis and healthy controls. Annals of the Rheumatic Diseases 68(8): 1345–1351.PubMedCrossRef Zhang, L., L.B. Jarvis, H.J. Baek, et al. 2009. Regulatory IL4 CD8 T cells in patients with ankylosing spondylitis and healthy controls. Annals of the Rheumatic Diseases 68(8): 1345–1351.PubMedCrossRef
10.
go back to reference Hillhouse, E.E., J.S. Delisle, and S. Lesage. 2013. Immunoregulatory CD4 (−) CD8 (−) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Frontiers in Immunology 4: 6.PubMedCentralPubMedCrossRef Hillhouse, E.E., J.S. Delisle, and S. Lesage. 2013. Immunoregulatory CD4 (−) CD8 (−) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Frontiers in Immunology 4: 6.PubMedCentralPubMedCrossRef
11.
go back to reference Miyake, S., and T. Yamamura. 2005. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 5(3): 315–322.PubMedCrossRef Miyake, S., and T. Yamamura. 2005. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 5(3): 315–322.PubMedCrossRef
12.
go back to reference Éric Toussirot. 2012. The IL23/Th17 Pathway as a therapeutic target in chronic inflammatory diseases. Bentham Science Publishers. 11(2):159–168. Éric Toussirot. 2012. The IL23/Th17 Pathway as a therapeutic target in chronic inflammatory diseases. Bentham Science Publishers. 11(2):159–168.
13.
go back to reference Lei Zhang, Yong-gang Li, et al. 2012. Increased frequencies of Th22 Cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. Plos One 4(7). Lei Zhang, Yong-gang Li, et al. 2012. Increased frequencies of Th22 Cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. Plos One 4(7).
14.
go back to reference Wang, D., M. Zheng, L. Lei, et al. 2012. TESPA1 is involved in late thymocyte development through the regulation of TCR-mediated signaling. Nature Immunology 13(6): 560–569.PubMedCrossRef Wang, D., M. Zheng, L. Lei, et al. 2012. TESPA1 is involved in late thymocyte development through the regulation of TCR-mediated signaling. Nature Immunology 13(6): 560–569.PubMedCrossRef
15.
go back to reference Matsuzaki, H., T. Fujimoto, M. Tanaka, and S. Shirasawa. 2013. TESPA1 is a novel component of mitochondria-associated endoplasmic reticulum membranes and affects mitochondrial calcium flux. Biochemical and Biophysical Research Communications 433: 322–326.PubMedCrossRef Matsuzaki, H., T. Fujimoto, M. Tanaka, and S. Shirasawa. 2013. TESPA1 is a novel component of mitochondria-associated endoplasmic reticulum membranes and affects mitochondrial calcium flux. Biochemical and Biophysical Research Communications 433: 322–326.PubMedCrossRef
16.
go back to reference Fujimoto, T., H. Matsuzaki, M. Tanaka, and S. Shirasawa. 2013. TESPA1 protein is phosphorylated in response to store-operated calcium entry. Biochemical and Biophysical Research Communications 434: 162–165.PubMedCrossRef Fujimoto, T., H. Matsuzaki, M. Tanaka, and S. Shirasawa. 2013. TESPA1 protein is phosphorylated in response to store-operated calcium entry. Biochemical and Biophysical Research Communications 434: 162–165.PubMedCrossRef
17.
go back to reference Van der Linden, S., H.A. Valkenburg, and A. Cats. 1984. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 27: 361–368.PubMedCrossRef Van der Linden, S., H.A. Valkenburg, and A. Cats. 1984. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 27: 361–368.PubMedCrossRef
18.
go back to reference Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Research 19: 519–523. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://​analysis.​bio-x.​cn). Cell Research 19: 519–523.
19.
go back to reference Shi, Y.Y., and L. He. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci [J]. Cell Research 15(2): 97–98.PubMedCrossRef Shi, Y.Y., and L. He. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci [J]. Cell Research 15(2): 97–98.PubMedCrossRef
20.
go back to reference Nicholas, R.J. 2012. Gascoigne, Guo Fu. TESPA1: another gatekeeper for positive selection. Nature Immunology 13(6): 530–532.CrossRef Nicholas, R.J. 2012. Gascoigne, Guo Fu. TESPA1: another gatekeeper for positive selection. Nature Immunology 13(6): 530–532.CrossRef
Metadata
Title
Lack of Association Between TESPA1 Gene Polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and Ankylosing Spondylitis in a Chinese Population
Authors
Si Liu
Li Liu
Shanshan Wu
Ting Yang
Faming Pan
Laura Laslett
Guo Xia
Yanting Hu
Dazhi Fan
Ning Ding
Shengqian Xu
Guoqi Cai
Li Wang
Lihong Xin
Publication date
01-12-2014
Publisher
Springer US
Published in
Inflammation / Issue 6/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9936-8

Other articles of this Issue 6/2014

Inflammation 6/2014 Go to the issue